COMMUNIQUÉS West-GlobeNewswire

Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
28/10/2025
BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans [...]
Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Diseases
28/10/2025
Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body’s natural mechanism to induce central tolerance Lead program in Type 1 diabetes is [...]
Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025
28/10/2025
CHATHAM, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biopharmaceutical company announced today that Seth Lederman [...]
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
28/10/2025
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board Brings substantial expertise in development of first-in-class disease-modifying therapies in dementia across multiple novel [...]
Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding the diversity of TPD medicines at the 8th Annual TPD & Induced Proximity Summit 2025
28/10/2025
Presentation will showcase the novel mechanisms of degradation of Amphista's Targeted Glues™, which recruit diverse E3 ligases, including DCAF16 and FBXO22, expanding the diversity and opportunity for TPD medicines. The [...]
KFSHRC inaugure la première usine de fabrication de thérapies géniques et cellulaires en Arabie saoudite
28/10/2025
RIYAD, Arabie saoudite, 28 oct. 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre a annoncé qu’il ouvrirait la première usine d’Arabie saoudite pour la fabrication de thérapies génétiques [...]
Regeneron Reports Third Quarter 2025 Financial and Operating Results
28/10/2025
Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter 2024 Dupixent ® global net sales (recorded by Sanofi) increased 27% to $4.86 billion EYLEA HD ® U.S. net sales increased 10% to $431 million [...]
PL BioScience Announces new Board Member Ole Henrik Bang-Andreasen
28/10/2025
AACHEN, Germany, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion and manufacturing, [...]
Upgrade of guidance
28/10/2025
ANNOUNCEMENT NO. 295 28 October 2025 Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive trend in revenue and [...]
Orion Group Interim Report January–September 2025
28/10/2025
ORION CORPORATION INTERIM REPORT 1–9/2025 28 OCTOBER 2025 at 12:00 EET Orion Group Interim Report January–September 2025 July–September 2025 Highlights Net sales totalled EUR 423.2 (July–September 2024: 471.3) million [...]
Zymeworks Announces Participation in Upcoming Investor Conferences
28/10/2025
VANCOUVER, British Columbia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]
Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines
28/10/2025
COPENHAGEN, Denmark, October 28, 2025 – Bavarian Nordic announced today a donation of mpox vaccines to Africa CDC to support the response to the ongoing mpox outbreak in Africa. The donation of 110,000 doses of the [...]
Swarm Oncology announces research collaboration with a leading hospital to advance T cell therapies for advanced solid cancers
28/10/2025
London, United Kingdom October 28, 2025, Swarm Oncology Ltd. (“Swarm Oncology” or “Swarm”), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with advanced solid [...]
Novartis announces expiration of Tourmaline Bio tender offer
28/10/2025
Basel, October 28 2025 - Novartis today announced that its previously announced tender offer (the “offer”) by Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“ [...]
Kyowa Kirin and Orchard Therapeutics Announce OTL-200 Granted Orphan Regenerative Medicine Product Designation for Early-onset MLD in Japan
28/10/2025
– First and only disease-modifying therapy for the treatment of eligible children with MLD also receives Orphan Drug Designation and Priority Review in the Kingdom of Saudi Arabia – TOKYO, LONDON and BOSTON, Oct. 28, [...]
Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance
28/10/2025
Ad hoc announcement pursuant to Art. 53 LR Q3 net sales grew +7% (cc 1 , +8% USD) and core operating income 1 grew +7% (cc, +6% USD) Sales growth was driven by continued strong execution on priority brands including [...]
Press release: Sanofi successfully prices USD 3 billion of bond issue
28/10/2025
Sanofi successfully prices USD 3 billion of bond issue Paris, France – October 28, 2025 - Sanofi announces that it has successfully priced its offering of $3 billion of notes across 5 tranches: $400 million fixed rate [...]
Communiqué de presse : Sanofi place 3 milliards de dollars d’emprunts obligataires
28/10/2025
Sanofi place 3 milliards de dollars d’emprunts obligataires Paris, 28 Octobre 2025 - Sanofi annonce avoir placé avec succès une émission obligataire en 5 tranches (les « obligations ») pour un montant de 3 milliards de [...]
Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome
28/10/2025
Gazyva/Gazyvaro versus mycophenolate mofetil shows significantly more children and young adults achieved sustained complete remission at week 52 If approved, Gazyva/Gazyvaro could help children and young adults sustain [...]

Pages